We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
52 hedge funds and large institutions have $32.9M invested in CASI Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
0.01% more ownership
Funds ownership: 1.2% → 1.2% (+0.01%)
4% less funds holding
Funds holding: 54 → 52 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
28% less capital invested
Capital invested by funds: $45.9M → $32.9M (-$13M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
52
Holders Change
-2
Holders Change %
-3.7%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
16
Reduced
15
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$406K |
| 2 |
WG
Winton Group
London,
United Kingdom
|
+$176K |
| 3 |
WSC
Wellington Shields & Co
New York
|
+$160K |
| 4 |
Renaissance Technologies
New York
|
+$146K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$137K |
